AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.015
-0.025 (-0.62%)
At close: May 15, 2026, 4:00 PM EDT
4.310
+0.295 (7.35%)
Pre-market: May 18, 2026, 6:03 AM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.47 billion as of May 18, 2026. Its market cap has increased by 401.59% in one year.
Market Cap
1.47B
Enterprise Value
1.24B
1-Year Change
401.59%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.47B, a decrease of -35.63%. That is a compound annual growth rate of -8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.47B | -0.83% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.54B |
| Ardelyx | 1.54B |
| Monte Rosa Therapeutics | 1.53B |
| Nuvation Bio | 1.50B |
| Novavax | 1.49B |
| Damora Therapeutics | 1.48B |
| Vir Biotechnology | 1.48B |
| Immatics | 1.46B |